The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
- PMID: 27508501
- DOI: 10.1159/000447034
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
Abstract
Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment for major depressive disorders and are considered to be safer than tricyclic agents. In this critical review, we evaluated the literature on adverse events, tolerability and safety of selective serotonin reuptake inhibitors, serotonin noradrenaline reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran and vortioxetine. Several side effects are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later. They encompass gastrointestinal symptoms (nausea, diarrhea, gastric bleeding, dyspepsia), hepatotoxicity, weight gain and metabolic abnormalities, cardiovascular disturbances (heart rate, QT interval prolongation, hypertension, orthostatic hypotension), genitourinary symptoms (urinary retention, incontinence), sexual dysfunction, hyponatremia, osteoporosis and risk of fractures, bleeding, central nervous system disturbances (lowering of seizure threshold, extrapyramidal side effects, cognitive disturbances), sweating, sleep disturbances, affective disturbances (apathy, switches, paradoxical effects), ophthalmic manifestations (glaucoma, cataract) and hyperprolactinemia. At times, such adverse events may persist after drug discontinuation, yielding iatrogenic comorbidity. Other areas of concern involve suicidality, safety in overdose, discontinuation syndromes, risks during pregnancy and breast feeding, as well as risk of malignancies. Thus, the rational selection of ADs should consider the potential benefits and risks, likelihood of responsiveness to the treatment option and vulnerability to adverse events. The findings of this review should alert the physician to carefully review the appropriateness of AD prescription on an individual basis and to consider alternative treatments if available.
© 2016 S. Karger AG, Basel.
Similar articles
-
Antidepressant Drugs Effects on Blood Pressure.Front Cardiovasc Med. 2021 Aug 3;8:704281. doi: 10.3389/fcvm.2021.704281. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34414219 Free PMC article. Review.
-
The Cardiovascular Effects of Newer Antidepressants in Older Adults and Those With or At High Risk for Cardiovascular Diseases.CNS Drugs. 2020 Nov;34(11):1133-1147. doi: 10.1007/s40263-020-00763-z. CNS Drugs. 2020. PMID: 33064291 Free PMC article. Review.
-
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. Encephale. 2009. PMID: 19748369 French.
-
Antidepressant drugs: disturbing and potentially dangerous adverse effects.J Clin Psychiatry. 1998;59 Suppl 16:25-30; discussion 40-2. J Clin Psychiatry. 1998. PMID: 9796863 Review.
-
Cardiovascular toxicity of antidepressant medications.Psychopathology. 1987;20 Suppl 1:64-74. doi: 10.1159/000284525. Psychopathology. 1987. PMID: 3321132 Review.
Cited by
-
Neuroleptic malignant syndrome and serotonin syndrome: a comparative bibliometric analysis.Orphanet J Rare Dis. 2024 Jun 2;19(1):221. doi: 10.1186/s13023-024-03227-5. Orphanet J Rare Dis. 2024. PMID: 38825678 Free PMC article. Review.
-
Antidepressant-induced membrane trafficking regulates blood-brain barrier permeability.Mol Psychiatry. 2024 May 30. doi: 10.1038/s41380-024-02626-1. Online ahead of print. Mol Psychiatry. 2024. PMID: 38816584
-
ProMENDA: an updated resource for proteomic and metabolomic characterization in depression.Transl Psychiatry. 2024 May 30;14(1):229. doi: 10.1038/s41398-024-02948-2. Transl Psychiatry. 2024. PMID: 38816410 Free PMC article.
-
Regulation of Antidepressant Prescription for the Effective Treatment of Mental Disorders in Turkey: A Narrative Review.Psychiatry Clin Psychopharmacol. 2022 Sep 1;32(3):250-261. doi: 10.5152/pcp.2022.22408. eCollection 2022 Sep. Psychiatry Clin Psychopharmacol. 2022. PMID: 38766671 Free PMC article. Review.
-
Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine.Ann Gen Psychiatry. 2024 May 16;23(1):20. doi: 10.1186/s12991-024-00505-1. Ann Gen Psychiatry. 2024. PMID: 38755657 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical